{
    "code": "02024294",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024294",
    "time": "2020-07-24 06:07:37",
    "許可證字號": "衛署藥輸字第024294號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/07",
    "發證日期": "94\/09\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202429403",
    "中文品名": "康皕庚眼用液劑",
    "英文品名": "COMBIGAN EYE DROPS",
    "適應症": "適用於慢性隅角開放性青光眼及慢性隅角閉鎖性青光眼合併已接受為暢通的周邊虹膜切除術或高眼壓病人，當以上病患使用單方降眼壓製劑控制效果不佳時，本品可作為降眼壓之用。",
    "劑型": "472點眼液劑",
    "包裝": "100毫升以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TIMOLOL MALEATE, BRIMONIDINE TARTRATE",
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "620118K767  台灣愛力根藥品股份有限公司",
    "申請商地址": "台北市中正區羅斯福路2段102號9樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIE0008000  ALLERGAN PHARMACEUTICALS IRELAND",
            "製造廠廠址": "CASTLEBAR ROAD, WESTPORT,  CO. MAYO, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216001910",
            "成分名稱": "TIMOLOL MALEATE",
            "含量描述": "",
            "含量": "6.8000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2408005310",
            "成分名稱": "BRIMONIDINE TARTRATE",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Combigan final PI_27May2014-103-06-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024294&Seq=010&Type=9"
        },
        {
            "title": "63165UT10C-103-06-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024294&Seq=007&Type=8"
        }
    ]
}